E-LIB Suche - Ergebnisse für: Iwanaga, Terunao

1

Clinical risk factors for portal hypertension-related compl..:

Fujiwara, Kisako ; Kondo, Takayuki ; Fujimoto, Kentaro...
Journal of Gastroenterology. 59 (2024) 6 - p. 515-525 , 2024

Link: https://doi.org/10.1007/..

2

Hyperprogressive disease during atezolizumab plus bevacizum..:

Yumita, Sae ; Ogasawara, Sadahisa ; Nakagawa, Miyuki...
BMC Gastroenterology. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

3

Endoscopic papillary large balloon dilatation‐assisted retr..:

Kamezaki, Hidehiro ; Yoshikawa, Hiroshi ; Iwanaga, Terunao...
DEN Open. 4 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

4

Miglustat, a glucosylceramide synthase inhibitor, mitigates..:

Iwanaga, Terunao ; Chiba, Tetsuhiro ; Nakamura, Masato...
Biochemical and Biophysical Research Communications. 642 (2023) - p. 192-200 , 2023

Link: https://doi.org/10.1016/..

5

Cabozantinib for Advanced Hepatocellular Carcinoma in the L..:

Kanzaki, Hiroaki ; Ogasawara, Sadahisa ; Okubo, Tomomi...
Drugs - Real World Outcomes. 10 (2023) 4 - p. 513-520 , 2023

Link: https://doi.org/10.1007/..

6

Alteration of the tumor microenvironment by pharmacological..:

Qiang, Na ; Ao, Junjie ; Nakamura, Masato...
International Immunopharmacology. 118 (2023) - p. 110068 , 2023

Link: https://doi.org/10.1016/..

7

Estimation of the effect of atezolizumab plus bevacizumab o..:

Kondo, Takayuki ; Fujiwara, Kisako ; Nakagawa, Miyuki...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

Use of ramucirumab for various treatment lines in real-worl..:

Kanogawa, Naoya ; Ogasawara, Sadahisa ; Maruta, Susumu...
BMC Gastroenterology. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

9

Potential of circulating receptor-interacting protein kinas..:

Kondo, Takayuki ; Fujimoto, Kentaro ; Fujiwara, Kisako...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Risk prediction of hepatic encephalopathy after molecular t..:

Fujiwara, Kisako ; Kondo, Takayuki ; Yumita, Sae...
Journal of Hepatology. 77 (2022) - p. S615-S616 , 2022

Link: https://doi.org/10.1016/..

11

Effect of Atezolizumab plus Bevacizumab in Patients with He..:

Ogawa, Keita ; Kanzaki, Hiroaki ; Chiba, Tetsuhiro...
Journal of Cancer. 13 (2022) 8 - p. 2656-2661 , 2022

Link: https://doi.org/10.7150/..

12

Clinical features of exacerbation of portal vein thrombosis..:

Kondo, Takayuki ; Fujiwara, Kisako ; Yumita, Sae...
Journal of Hepatology. 77 (2022) - p. S897-S898 , 2022

Link: https://doi.org/10.1016/..

13

Su1355: INVESTIGATION OF AUTOIMMUNE MECHANISMS SHARED IN CD..:

ZHANG, JIAQI ; Ohta, Yuki ; Nakagawa, Ryo...
Gastroenterology. 162 (2022) 7 - p. S-1195 , 2022

Link: https://doi.org/10.1016/..

14

The efficacy of contrast-enhanced computed tomography on th..:

Kondo, Takayuki ; Fujiwara, Kisako ; Nakagawa, Miyuki...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

15

Durvalumab with or without tremelimumab combined with parti..:

Ogasawara, Sadahisa ; Koroki, Keisuke ; Makishima, Hirokazu...
BMJ Open. 12 (2022) 4 - p. e059779 , 2022

Link: https://doi.org/10.1136/..